{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:47:23Z","timestamp":1762004843080,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,12,26]],"date-time":"2016-12-26T00:00:00Z","timestamp":1482710400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000810","name":"Executive Agency for Health and Consumers","doi-asserted-by":"publisher","award":["A 2009-11-01"],"award-info":[{"award-number":["A 2009-11-01"]}],"id":[{"id":"10.13039\/501100000810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s10096-016-2869-4","type":"journal-article","created":{"date-parts":[[2016,12,26]],"date-time":"2016-12-26T03:01:17Z","timestamp":1482721277000},"page":"839-846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Surveillance of Gram-negative bacteria: impact of variation in current European laboratory reporting practice on apparent multidrug resistance prevalence in paediatric bloodstream isolates"],"prefix":"10.1007","volume":"36","author":[{"name":"for the ARPEC project","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Bielicki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. A.","family":"Cromwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Planche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sharland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,26]]},"reference":[{"issue":"2","key":"2869_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/cid\/cir838","volume":"54","author":"C Pulcini","year":"2012","unstructured":"Pulcini C, Bush K, Craig WA et al (2012) Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia. Clin Infect Dis 54(2):268\u2013274","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2869_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001104","volume":"8","author":"ME Kraker de","year":"2011","unstructured":"de Kraker ME, Davey PG, Grundmann H (2011) Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med 8(10), e1001104","journal-title":"PLoS Med"},{"issue":"1","key":"2869_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2334-5-24","volume":"5","author":"ME Falagas","year":"2005","unstructured":"Falagas ME, Bliziotis IA, Kasiakou SK et al (2005) Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis 5(1):24","journal-title":"BMC Infect Dis"},{"issue":"3","key":"2869_CR4","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1128\/AAC.01169-07","volume":"52","author":"CG Giske","year":"2008","unstructured":"Giske CG, Monnet DL, Cars O et al (2008) Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 52(3):813\u2013821","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2869_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jhin.2015.01.008","volume":"89","author":"PM Hawkey","year":"2015","unstructured":"Hawkey PM (2015) Multidrug-resistant Gram-negative bacteria: a product of globalization. J Hosp Infect 89(4):241\u2013247","journal-title":"J Hosp Infect"},{"issue":"254","key":"2869_CR6","doi-asserted-by":"publisher","first-page":"254ra126","DOI":"10.1126\/scitranslmed.3009845","volume":"6","author":"S Conlan","year":"2014","unstructured":"Conlan S, Thomas PJ, Deming C et al (2014) Single-molecule sequencing to track plasmid diversity of hospital-associated carbapenemase-producing Enterobacteriaceae. Sci Transl Med 6(254):254ra126","journal-title":"Sci Transl Med"},{"key":"2869_CR7","volume-title":"Antimicrobial resistance: global report on surveillance","author":"World Health Organization (WHO)","year":"2014","unstructured":"World Health Organization (WHO) (2014) Antimicrobial resistance: global report on surveillance. WHO, Geneva"},{"issue":"2","key":"2869_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1128\/CMR.00021-10","volume":"24","author":"TF O\u2019Brien","year":"2011","unstructured":"O\u2019Brien TF, Stelling J (2011) Integrated multilevel surveillance of the world\u2019s infecting microbes and their resistance to antimicrobial agents. Clin Microbiol Rev 24(2):281\u2013295","journal-title":"Clin Microbiol Rev"},{"issue":"4\u20135","key":"2869_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.drup.2010.08.002","volume":"13","author":"CG Giske","year":"2010","unstructured":"Giske CG, Cornaglia G; ESCMID Study Group on Antimicrobial Resistance Surveillance (ESGARS) (2010) Supranational surveillance of antimicrobial resistance: the legacy of the last decade and proposals for the future. Drug Resist Updat 13(4\u20135):93\u201398","journal-title":"Drug Resist Updat"},{"issue":"6","key":"2869_CR10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1046\/j.1198-743x.2001.00239.x","volume":"7","author":"R Bax","year":"2001","unstructured":"Bax R, Bywater R, Cornaglia G et al (2001) Surveillance of antimicrobial resistance\u2014what, how and whither? Clin Microbiol Infect 7(6):316\u2013325","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"2869_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268\u2013281","journal-title":"Clin Microbiol Infect"},{"key":"2869_CR12","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2010) Reporting protocol. EARS-Net 2010"},{"key":"2869_CR13","volume-title":"UK five year antimicrobial resistance strategy 2013 to 2018","author":"Department of Health and Department for Environment Food & Rural Affairs","year":"2013","unstructured":"Department of Health and Department for Environment Food & Rural Affairs (2013) UK five year antimicrobial resistance strategy 2013 to 2018. Department of Health, London"},{"key":"2869_CR14","volume-title":"Multidrug-resistant organism & Clostridium difficile infection (MDRO\/CDI) module","author":"National Healthcare Safety Network (NHSN)","year":"2014","unstructured":"National Healthcare Safety Network (NHSN) (2014) Multidrug-resistant organism & Clostridium difficile infection (MDRO\/CDI) module. Centers for Disease Control and Prevention (CDC), Atlanta"},{"key":"2869_CR15","volume-title":"The bacterial challenge: time to react","author":"European Centre for Disease Prevention and Control (ECDC) and European Medicines Agency (EMA)","year":"2009","unstructured":"European Centre for Disease Prevention and Control (ECDC) and European Medicines Agency (EMA) (2009) The bacterial challenge: time to react. ECDC, Stockholm"},{"issue":"6","key":"2869_CR16","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/jac\/dkh229","volume":"53","author":"ML Heginbothom","year":"2004","unstructured":"Heginbothom ML, Magee JT, Bell JL et al (2004) Laboratory testing policies and their effects on routine surveillance of community antimicrobial resistance. J Antimicrob Chemother 53(6):1010\u20131017","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"2869_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1469-0691.2007.01946.x","volume":"14","author":"A Wimmerstedt","year":"2008","unstructured":"Wimmerstedt A, Kahlmeter G (2008) Associated antimicrobial resistance in Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes. Clin Microbiol Infect 14(4):315\u2013321","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"2869_CR18","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/jac\/dkq010","volume":"65","author":"AJ Smith","year":"2010","unstructured":"Smith AJ, Lockhart DE, Tyers A et al (2010) A survey of the identification and susceptibility testing of anaerobes in diagnostic microbiology laboratories in Scotland, UK. J Antimicrob Chemother 65(4):805","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"2869_CR19","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1128\/JCM.00184-07","volume":"45","author":"JM Counts","year":"2007","unstructured":"Counts JM, Astles JR, Tenover FC et al (2007) Systems approach to improving antimicrobial susceptibility testing in clinical laboratories in the United States. J Clin Microbiol 45(7):2230\u20132234","journal-title":"J Clin Microbiol"},{"issue":"7","key":"2869_CR20","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/INF.0000000000000652","volume":"34","author":"JA Bielicki","year":"2015","unstructured":"Bielicki JA, Lundin R, Sharland M et al (2015) Antibiotic resistance prevalence in routine bloodstream isolates from children\u2019s hospitals varies substantially from adult surveillance data in Europe. Pediatr Infect Dis J 34(7):734\u2013741","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"2869_CR21","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/jac\/dkv397","volume":"71","author":"JA Bielicki","year":"2016","unstructured":"Bielicki JA, Sharland M, Johnson AP et al (2016) Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data. J Antimicrob Chemother 71(3):794\u2013802","journal-title":"J Antimicrob Chemother"},{"key":"2869_CR22","unstructured":"(2012) Antibiotic Resistance and Prescribing in European Children. 15\/11\/2012"},{"key":"2869_CR23","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Home page at: \nhttp:\/\/www.eucast.org\/\n\n. Accessed 5 Sept 2016"},{"key":"2869_CR24","unstructured":"British Society for Antimicrobial Chemotherapy (BSAC). Susceptibility testing method\u2014latest version. Available online at: \nhttp:\/\/bsac.org.uk\/stewardship-surveillance\/susceptibility\/methodologylatestversion\/\n\n. Accessed 5 Sept 2016"},{"key":"2869_CR25","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Subcommittee on Antimicrobial Susceptibility Testing (AST) (2013) Standards. Available online at: \nhttp:\/\/www.clsi.org\/standards\/micro\/sub-ast\/\n\n. Accessed 5 Sept 2016"},{"key":"2869_CR26","unstructured":"Comit\u00e9 de l\u2019antibiogramme de la Soci\u00e9t\u00e9 Francaise de Microbiologie (CASFM) (2011) Recommandations 2011. Paris, France"},{"key":"2869_CR27","unstructured":"Comit\u00e9 de l\u2019antibiogramme de la Soci\u00e9t\u00e9 Francaise de Microbiologie (CASFM) (2012) Recommandations 2012. Paris, France"},{"issue":"12","key":"2869_CR28","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1017\/S0950268809990100","volume":"137","author":"OR Rempel","year":"2009","unstructured":"Rempel OR, Laupland KB (2009) Surveillance for antimicrobial resistant organisms: potential sources and magnitude of bias. Epidemiol Infect 137(12):1665\u20131673","journal-title":"Epidemiol Infect"},{"issue":"12","key":"2869_CR29","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nrmicro1047","volume":"2","author":"MJ Schwaber","year":"2004","unstructured":"Schwaber MJ, De-Medina T, Carmeli Y (2004) Epidemiological interpretation of antibiotic resistance studies\u2014what are we missing? Nat Rev Microbiol 2(12):979\u2013983","journal-title":"Nat Rev Microbiol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2869-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-016-2869-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2869-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T08:31:42Z","timestamp":1492504302000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-016-2869-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,26]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["2869"],"URL":"https:\/\/doi.org\/10.1007\/s10096-016-2869-4","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2016,12,26]]}}}